Tenax Therapeutics (FRA:YBO0) FFO


FRA:YBO0 Tenax Therapeutics Inc FRA:YBO0
34 GF Score
Price €10.90
! 2 Warning Signs
View Full Analysis

What is Tenax Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:YBO0
34GF Score
Tenax Therapeutics Inc FRA:YBO0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tenax Therapeutics Business Description

Other Exchanges TENX:USA
Address 101 Glen Lennox Drive, Suite 300, Chapel Hill, NC, USA, 27517
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
34GF Score

Get the complete analysis for FRA:YBO0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.90
Price